Mitochondria-Targeted Antioxidant SS31 Prevents Amyloid Beta-Induced Mitochondrial Abnormalities and Synaptic Degeneration in Alzheimer’s Disease

समान संसाधन

• Mitochondria-Targeted Antioxidant SS31 Prevents Amyloid Beta-Induced Mitochondrial Abnormalities and Synaptic Degeneration in Alzheimer’s Disease
  द्वारा: Marcus J. Calkins, और अन्य
  प्रकाशित: (2012-10-01)
• Abnormal Mitochondrial Dynamics and Synaptic Degeneration as Early Events in Alzheimer’s Disease: Implications to Mitochondria-Targeted Antioxidant Therapeutics
  द्वारा: Reddy, P. Hemachandra, और अन्य
  प्रकाशित: (2011)
• Toxicity of Neurons Treated with Herbicides and Neuroprotection by Mitochondria-Targeted Antioxidant SS31
  द्वारा: Reddy, Tejaswini P., और अन्य
  प्रकाशित: (2011)
• Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease
  द्वारा: Calkins, Marcus J., और अन्य
  प्रकाशित: (2011)
• Amyloid-β and Mitochondria in Aging and Alzheimer’s Disease: Implications for Synaptic Damage and Cognitive Decline
  द्वारा: Reddy, P. Hemachandra, और अन्य
  प्रकाशित: (2010)